The notices it replaced
- Reissues: RFA-CA-14-004 Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
- 2 steps back: RFA-CA-13-002 Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
- 3 steps back: RFA-CA-12-003 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
- 4 steps back: RFA-CA-10-004 Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)
- 5 steps back: RFA-CA-09-007 Application and Use of Transformative Emerging Technologies in Cancer Research (R33)
- 6 steps back: RFA-CA-08-008
- 7 steps back: RFA-CA-07-036
- 8 steps back: RFA-CA-07-018
- 9 steps back: RFA-CA-07-002
- 10 steps back: RFA-CA-06-003
- 11 steps back: RFA-CA-05-003
Replaced by RFA-CA-16-002.
Who won it before
33 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,515,419 in first-year total cost, median $375,858.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-Q (O2)]10
- Special Emphasis Panel[ZCA1 TCRB-9 (M1)]7
- Special Emphasis Panel[ZCA1 TCRB-Q (J1)]5
- Special Emphasis Panel[ZCA1 SRLB-Q (J2)]4
- Special Emphasis Panel[ZCA1 TCRB-5 (M1)]3
Most frequent institutions
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS2
- UNIVERSITY OF CALIFORNIA-IRVINE2
- UNIVERSITY OF WASHINGTON2
- BIOSPYDER TECHNOLOGIES, INC.1
- BROAD INSTITUTE, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology1R33CA206949-01 | SPICER, TIMOTHY PATRICK | SCRIPPS FLORIDA, FL | $501,426 | ZCA1 |
| 2016 | Clinical implementation of single cell tumor transcriptome analysis1R33CA202820-01 | REGEV, AVIV | BROAD INSTITUTE, INC., MA | $457,465 | ZCA1 |
| 2016 | Analysis of scant cancer cells in fine needle aspirates1R33CA202064-01 | WEISSLEDER, MD, PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL, MA | $433,261 | ZCA1 |
| 2016 | A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers1R33CA202900-01 | BREUNIG, JOSHUA JOHN | CEDARS-SINAI MEDICAL CENTER, CA | $418,128 | ZCA1 |
| 2016 | Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma1R33CA196470-01A1 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | $394,518 | ZCA1 |
| 2016 | Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology1R33CA196458-01A1 | BHARGAVA, ROHITCHEVILLE, JOHN C | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $387,693 | ZCA1 |
| 2016 | Charge sensitive optical detection for high-throughput study of small molecules1R33CA202834-01A1 | TAO, NONGJIAN | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $381,382 | ZCA1 |
| 2016 | Online Raman Diagnostics of Oncometabolites1R33CA206922-01 | SCHULTZ, ZACHARY | UNIVERSITY OF NOTRE DAME, IN | $363,875 | ZCA1 |
| 2016 | GESI: a novel technology for functional imaging in living cells1R33CA196445-01A1 | LAM, KIT S | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $362,749 | ZCA1 |
| 2016 | Protein painting identifies therapeutic targets at protein-protein interfaces1R33CA206937-01 | LIOTTA, LANCE ALLEN | GEORGE MASON UNIVERSITY, VA | $348,203 | ZCA1 |
| 2016 | High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing1R33CA202867-01 | NAGRATH, SUNITHARAMNATH, NITHYA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $343,664 | ZCA1 |
| 2016 | A novel molecular assay for early detection and assessment of cancer risk1R33CA202898-01 | QUEIMADO, LURDES | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $340,594 | ZCA1 |
| 2016 | Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors1R33CA206955-01 | WEISS, GREGORY A. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $322,131 | ZCA1 |
| 2016 | Large-Scale Integration of Single Cell RNA-Seq and High-Content Imaging for Analyzing Drug Response in Cancer1R33CA202827-01 | SIMS, PETER ALAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $316,149 | ZCA1 |
| 2016 | Brillouin confocal microscopy for biomechanical studies of metastatic cascade in 3D microenvironments1R33CA204582-01 | SCARCELLI, GIULIANO | UNIV OF MARYLAND, COLLEGE PARK, MD | $295,733 | ZCA1 |
| 2015 | Single cell cytokine analysis of circulating malignant hematopoietic cells1R33CA196411-01 · under RFA-CA-14-004 | FAN, RONGLEVINE, ROSS L | YALE UNIVERSITY, CT | $421,227 | ZCA1 |
| 2015 | High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis1R33CA182384-01A1 · under RFA-CA-14-004 | BURKE, PETER J. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $412,541 | ZCA1 |
| 2015 | Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis1R33CA191245-01A1 · under RFA-CA-14-004 | WU, YUN | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $411,504 | ZCA1 |
| 2015 | Development of a virion display (VirD) array to profile human GPCR interactions1R33CA186790-01A1 · under RFA-CA-14-004 | DESAI, PRASHANT JZHU, HENG | JOHNS HOPKINS UNIVERSITY, MD | $403,372 | ZCA1 |
| 2015 | A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes1R33CA191198-01 · under RFA-CA-14-004 | CARON, MARC G. | DUKE UNIVERSITY, NC | $389,963 | ZCA1 |
| 2015 | Using Adductomics to Characterize Exposures to Carcinogens1R33CA191159-01A1 · under RFA-CA-14-004 | RAPPAPORT, STEPHEN MORRIS | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $380,395 | ZCA1 |
| 2015 | Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations1R33CA192980-01 · under RFA-CA-14-004 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON, WA | $375,858 | ZCA1 |
| 2015 | Scalable Cancer Genomics via Nanocoding and Sequencing1R33CA182360-01A1 · under RFA-CA-14-004 | MA, JIANSCHWARTZ, DAVID C. | UNIVERSITY OF WISCONSIN-MADISON, WI | $372,503 | ZCA1 |
| 2015 | Fast interference-based super-resolution microscope for cancer mechanobiology1R33CA193043-01 · under RFA-CA-14-004 | ZIPFEL, WARREN R | CORNELL UNIVERSITY, NY | $364,273 | ZCA1 |
| 2015 | Single cell growth assay for residual cells in acute lymphoblastic leukemia1R33CA191143-01 · under RFA-CA-14-004 | MANALIS, SCOTT R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $363,946 | ZCA1 |
| 2015 | RASL-Seq Expression Profiling of FFPE Tissues1R33CA183688-01A1 · under RFA-CA-14-004 | YEAKLEY, JOANNE MULLIGAN | BIOSPYDER TECHNOLOGIES, INC., CA | $363,706 | ZCA1 |
| 2015 | Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research1R33CA191110-01 · under RFA-CA-14-004 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $317,654 | ZCA1 |
| 2014 | Integrating mass cytometric and transcriptomic profiles of solid tumors1R33CA183692-01 · under RFA-CA-13-002 | WEISS, WILLIAM A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $408,712 | ZCA1 |
| 2014 | Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci1R33CA183659-01 · under RFA-CA-13-002 | ROBINSON, WILLIAM H | STANFORD UNIVERSITY, CA | $399,643 | ZCA1 |
| 2014 | Validation and Advanced Development of Duplex Sequencing1R33CA181771-01A1 · under RFA-CA-13-002 | LOEB, LAWRENCE A | UNIVERSITY OF WASHINGTON, WA | $384,923 | ZCA1 |
| 2014 | Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics1R33CA177333-01A1 · under RFA-CA-13-002 | FEDERSPIEL, MARK J | MAYO CLINIC ROCHESTER, MN | $375,008 | ZCA1 |
| 2014 | Non-Circulating Microparticles for Improved Localization and Resection Cancer1R33CA177449-01A1 · under RFA-CA-13-002 | BLAIR, SARAH L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $361,766 | ZCA1 |
| 2014 | Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp1R33CA183671-01 · under RFA-CA-13-002 | PARKER, LAURIE L. | UNIVERSITY OF MINNESOTA, MN | $341,454 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.